AktiVax

AktiVaxTM develops novel reconstitution and safety syringes for vaccines and biologics.                           

AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners’ problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVax’s solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficient manufacturing for rapid market distribution. Our proposition has already attracted a number of vaccine partners representing a significant portion of the $30 billion vaccine industry. We believe that our solution will create a new standard of care in the vaccine market.